ASX300 Inches Toward Record High as Banks Rally and Nufarm Stumbles

3 min read | May 21, 2025 02:26 PM AEST | By Team Kalkine Media

Highlights

  • Big banks and utility stocks lift ASX near record highs
  • Nufarm and Mayne Pharma drag after company-specific updates
  • Market eyes next RBA decision after surprising rate cut

Australia’s benchmark index rallied on Wednesday afternoon, buoyed by strong performances from the nation’s major banks and utility companies. The S&P/ASX 200 gained 0.9%, adding 74.7 points to reach 8418 around midday—just 2% shy of its all-time high. The broader All Ordinaries mirrored this rise with a 0.9% increase.

Ten of the eleven sectors were in positive territory, led by utilities and financials. Optimism followed the Reserve Bank of Australia's recent decision to lower interest rates to 3.85%, sparking market speculation that further monetary easing could be on the horizon.

The RBA's unexpected openness to a deeper 50 basis point rate cut has created buzz in financial circles. The July 8 board meeting is now seen as a potential pivot point, with fixed income markets pricing in a heightened chance of continued easing.

Among the standout performers, Commonwealth Bank of Australia (ASX:CBA) extended its record-breaking run, climbing 2.2%. National Australia Bank (ASX:NAB) added 2.4%, while Westpac Banking Corporation (ASX:WBC) rose 1.1%, even as reports emerged about plans to reduce its workforce by more than 1,500 roles.

In the utilities space, Origin Energy (ASX:ORG) jumped 2% and APA Group (ASX:APA) advanced 2.3%. Healthcare stocks also saw gains, with ResMed Inc. (ASX:RMD) up 4.7% and Fisher & Paykel Healthcare Corporation (ASX:FPH) climbing 2.9%.

While broader sentiment remained upbeat, several individual stocks faced headwinds. Nufarm Ltd (ASX:NUF) dropped 28.1% after revising its earnings outlook downward. The agricultural chemical company cited reduced profits, impacted by lower fish oil prices and increased costs.

Mayne Pharma Group Ltd (ASX:MYX) tumbled 31% after its prospective acquirer, Cosette Pharmaceuticals, raised concerns about a potential material change in the company’s financial standing since making its $672 million offer.

Meanwhile, James Hardie Industries plc (ASX:JHX) fell 7% as it acknowledged softer-than-expected demand in the U.S. renovation market. This comes as the building materials company continues to pursue a $14 billion acquisition of Azek.

Elsewhere, Catapult Group International Ltd (ASX:CAT) surged 10.2% after reporting a 19% lift in revenue to US$116.5 million, helping narrow its annual loss. Adriatic Metals PLC (ASX:ADT) soared 23.9% amid news it is in due diligence talks with Dundee Precious Metals regarding a potential acquisition.

In contrast, Resimac Group Ltd (ASX:RMC) fell 2.9% after facing legal action from ASIC over allegations related to hardship applications management.

As the ASX300 pushes toward historic highs, income-focused investors are also revisiting potential opportunities in ASX dividend stocks, especially within the financial and utilities sectors, which remain central to the current momentum.

With global economic uncertainty and monetary policy shifts in focus, the coming weeks may continue to drive volatility and sector rotation within the ASX300 landscape.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.